RY 173.64 -0.3672% SHOP 148.58 -0.6486% TD 82.36 -0.9263% ENB 64.21 -0.2641% BN 83.24 -1.0579% TRI 230.54 0.013% CNQ 46.58 3.4881% CP 109.8 1.4131% CNR 148.11 0.8031% BMO 143.82 0.3489% BNS 73.94 0.5029% CSU 4345.0 -1.0785% CM 90.555 -0.1158% MFC 44.31 0.113% ATD 76.82 0.0521% NGT 60.2 -0.1327% TRP 69.31 1.0939% SU 56.975 0.9658% WCN 255.98 -0.7868% L 181.13 -0.1268%
Last update at
Maravai LifeSciences Announces Preliminary Unaudited 2024 Revenue
Wed 08 Jan 25, 09:10 PMMaravai Lifesciences initiated with a Neutral at Guggenheim
Fri 20 Dec 24, 12:15 PMExploring December 2024's Undervalued Small Caps With Insider Action In US
Thu 19 Dec 24, 10:04 AMMaravai LifeSciences Appoints R. Andrew Eckert as Chairman of the Board of Directors
Thu 05 Dec 24, 09:05 PMExploring ACNB And 2 More Undervalued Small Caps With Insider Buying In US
Wed 20 Nov 24, 10:05 AMMaravai LifeSciences Announces November 2024 Investor Conference Schedule
Tue 12 Nov 24, 01:05 PMQ3 2024 Maravai LifeSciences Holdings Inc Earnings Call
Fri 08 Nov 24, 07:20 PMMaravai LifeSciences Holdings Inc (MRVI) Q3 2024 Earnings Call Highlights: Navigating ...
Fri 08 Nov 24, 07:34 AMMaravai LifeSciences To Host Earnings Conference Call on Thursday, November 7, 2024
Tue 15 Oct 24, 08:05 PMBreakdown |
---|
Breakdown |
---|
Breakdown |
---|
Sector: Industry:
Company | Change () | Price () | Trailing PE (x) | Forward PE (x) | Price Sales TTM (x) | Price to Book Value (x) |
---|
Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.